. 2022 Apr;10(8):430. doi: 10.21037/atm-21-6326

Table 3. Kaplan-Meier survival analysis (in median days).

Variable	Total (n=70)	P₁	Lung cancer (n=50)	P₂	Breast cancer (n=20)	P₃
CD8 stromal ≤15	134	0.07	79	0.2	205	0.2
CD8 stromal >15	169	0.07	132	0.2	201	0.2
CD8 intratumoral ≤1	134	0.1	79	0.9	201	0.07
CD8 intratumoral >1	171	0.1	49	0.9	782	0.07
CD4 stromal ≤40	128	0.03	79	0.009	201	0.9
CD4 stromal >40	235	0.03	169	0.009	346	0.9
CD4 intratumoral ≤10	123	0.04	71	0.04	205	0.4
CD4 intratumoral >10	229	0.04	215	0.04	503	0.4
CD20 stromal ≤20	114	0.08	71	0.001	205	0.8
CD20 stromal >20	234	0.08	235	0.001	204	0.8
CD163 stromal ≤10	171	0.4	123	0.9	205	0.4
CD163 stromal >10	128	0.4	47	0.9	128	0.4
CD163 intratumoral ≤5	169	0.4	114	0.7	234	0.1
CD163 intratumoral >5	128	0.4	71	0.7	128	0.1
S100 stromal ≤3	123	0.02	47	0.0008	205	0.7
S100 stromal >3	260	0.02	260	0.0008	201	0.7
S100 intratumoral ≤2	128	0.04	59	0.02	176	0.07
S100 intratumoral >2	235	0.04	171	0.02	Not reached	0.07

Cut off values defined using ROC curves. P₁, P value between median days referring in the Total column; P₂, P value between median days referring in the Lung cancer column; P₃, P value between median days referring in the Breast cancer column. ROC, receiver operating characteristic.